Goddres Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.50 M
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.99 Cr
- Revenue Growth 37.15%
- Profit Growth 46.45%
- Ebitda 9.76%
- Net Worth 12.29%
- Total Assets 5.41%
About Goddres Pharmaceuticals
Goddres Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 January 2010 and has a history of 15 years and one month. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.50 M.
The company currently has active open charges totaling ₹9.99 Cr.
Rajesh Dewan, Gourango Mukherjee, Om Gupta, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MH2010PTC217851
- Company No.
217851
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Goddres Pharmaceuticals Private Limited offer?
Goddres Pharmaceuticals Private Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care, Pain Relief.
Who are the key members and board of directors at Goddres Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gourango Mukherjee  | Managing Director | 05-Feb-2010 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Dewan | Director | 05-Feb-2010 | Current |
| Om Gupta | Director | 12-Jan-2010 | Current |
| Dhirendra Deo | Director | 05-Feb-2010 | Current |
| Sanjay Kumar | Director | 12-Jan-2010 | Current |
| Dev Chatterjee | Director | 05-Feb-2010 | Current |
Financial Performance of Goddres Pharmaceuticals.
Goddres Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.15% increase. The company also saw a substantial improvement in profitability, with a 46.45% increase in profit. The company's net worth Soared by an impressive increase of 12.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Goddres Pharmaceuticals?
In 2023, Goddres Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Goddres Wellness Private LimitedGourango Mukherjee and Dev Chatterjee are mutual person
Canvarzys Healthcare LimitedRajesh Dewan is a mutual person
- Canvarzys Care Private Limited
Rajesh Dewan is a mutual person
Charges (Loans)
₹9.99 Cr
₹0
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 9.05 Cr
- Others : 0.94 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Aug 2022 | Others | ₹2.40 M | Open |
| 18 Jan 2021 | Others | ₹6.98 M | Open |
| 24 Sep 2012 | Icici Bank Limited | ₹9.05 Cr | Open |
How Many Employees Work at Goddres Pharmaceuticals?
Goddres Pharmaceuticals has a workforce of 248 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Goddres Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goddres Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
